Related Experiment Video
Updated: Feb 27, 2026

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated
Guillaume M Hautbergue1, Lydia M Castelli1, Laura Ferraiuolo1
1Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield S10 2HQ, UK.
Abstract:
Hexanucleotide repeat expansions in the C9ORF72 gene are the commonest known genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Expression of repeat transcripts and dipeptide repeat proteins trigger multiple mechanisms of neurotoxicity. How repeat transcripts get exported from the nucleus is unknown. Here, we show that depletion of the nuclear export adaptor SRSF1 prevents neurodegeneration and locomotor deficits in a Drosophila model of C9ORF72-related disease. This intervention suppresses cell death of patient-derived motor neuron and astrocytic-mediated neurotoxicity in co-culture assays. We further demonstrate that either depleting SRSF1 or preventing its interaction with NXF1 specifically inhibits the nuclear export of pathological C9ORF72 transcripts, the production of dipeptide-repeat proteins and alleviates neurotoxicity in Drosophila, patient-derived neurons and neuronal cell models. Taken together, we show that repeat RNA-sequestration of SRSF1 triggers the NXF1-dependent nuclear export of C9ORF72 transcripts retaining expanded hexanucleotide repeats and reveal a novel promising therapeutic target for neuroprotection.
Insights
Scientists discovered that blocking SRSF1, a nuclear export adaptor, prevents neurodegeneration in C9ORF72-related diseases. This finding offers a promising therapeutic target for neuroprotection against these devastating conditions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Hexanucleotide repeat expansions in the C9ORF72 gene are the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
- Pathological C9ORF72 repeat transcripts and resulting dipeptide repeat proteins induce neurotoxicity through various mechanisms.
- The nuclear export pathway for these toxic C9ORF72 repeat transcripts remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of nuclear export adaptors in the pathogenesis of C9ORF72-related neurodegenerative diseases.
- To identify potential therapeutic targets for preventing neurodegeneration caused by C9ORF72 mutations.
Main Methods:
- Utilized a Drosophila model of C9ORF72-related disease to assess the impact of SRSF1 depletion on neurodegeneration and motor deficits.
- Conducted co-culture assays with patient-derived motor neurons and astrocytes to evaluate neurotoxicity.
- Examined the interaction between SRSF1 and NXF1 and its effect on C9ORF72 transcript nuclear export and dipeptide-repeat protein production in various neuronal models.
Main Results:
- Depletion of SRSF1 significantly ameliorated neurodegeneration and locomotor impairments in the Drosophila model.
- Intervention targeting SRSF1 reduced cell death in patient-derived motor neurons and mitigated astrocytic-mediated neurotoxicity.
- Inhibition of SRSF1 or its interaction with NXF1 specifically blocked the nuclear export of pathogenic C9ORF72 transcripts, reduced dipeptide-repeat protein synthesis, and alleviated neurotoxicity across multiple models.
Conclusions:
- SRSF1 acts as a crucial mediator for the nuclear export of C9ORF72 transcripts containing expanded hexanucleotide repeats.
- The pathological RNA sequestration of SRSF1 facilitates NXF1-dependent nuclear export, contributing to neurotoxicity.
- Targeting the SRSF1-NXF1 interaction presents a novel and promising therapeutic strategy for neuroprotection in C9ORF72-related disorders.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Nuclear Export of mRNA
Regulation of Nuclear Protein Sorting
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...

